Gemfibrozil
- Product NDC
- 68071-2422
- 11-digit product format
- 680712422
- Labeler code
- 68071
- Product ID
- 68071-2422_c3542eba-3c1e-57ba-e053-2995a90a517b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- gemfibrozil
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA079072
- Marketing category
- ANDA
- Marketing start
- 2010-12-20
- Marketing end
- 0000-00-00
- Substance
- GEMFIBROZIL
- Active strength
- 600 mg/1
- Pharmacologic classes
- Peroxisome Proliferator-activated Receptor alpha Agonists [MoA],PPAR alpha [CS],Peroxisome Proliferator Receptor alpha Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68071-2422-8 | Gemfibrozil | 180 in 1 BOTTLE | TABLET | 180 | | 24 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68071-2422 | GEMFIBROZIL TABLET [NUCARE PHARMACEUTICALS,INC.] | 24 | Legacy NDC, 1 package rows | 20210528_c3542eba-3c1d-57ba-e053-2995a90a517b.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68071-2422-8 | 68071242208 | 180 TABLET in 1 BOTTLE (68071-2422-8) | 180 tablet | 2021-05-27 | 0000-00-00 | No | No | Current |